- Home
- FPH vs IMAB Comparison
FPH vs IMAB Comparison
Compare FPH & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPH
- IMAB
- Stock Information
- Founded
- FPH 2009
- IMAB 2014
- Country
- FPH United States
- IMAB United States
- Employees
- FPH N/A
- IMAB N/A
- Industry
- FPH Real Estate
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- FPH Finance
- IMAB Health Care
- Exchange
- FPH Nasdaq
- IMAB Nasdaq
- Market Cap
- FPH 390.0M
- IMAB 384.6M
- IPO Year
- FPH 2017
- IMAB 2020
- Fundamental
- Price
- FPH $5.88
- IMAB $4.08
- Analyst Decision
- FPH
- IMAB Strong Buy
- Analyst Count
- FPH 0
- IMAB 5
- Target Price
- FPH N/A
- IMAB $6.80
- AVG Volume (30 Days)
- FPH 139.0K
- IMAB 2.2M
- Earning Date
- FPH 10-16-2025
- IMAB 11-02-2025
- Dividend Yield
- FPH N/A
- IMAB N/A
- EPS Growth
- FPH 46.82
- IMAB N/A
- EPS
- FPH 1.08
- IMAB N/A
- Revenue
- FPH $197,429,000.00
- IMAB N/A
- Revenue This Year
- FPH N/A
- IMAB N/A
- Revenue Next Year
- FPH N/A
- IMAB N/A
- P/E Ratio
- FPH $5.48
- IMAB N/A
- Revenue Growth
- FPH N/A
- IMAB N/A
- 52 Week Low
- FPH $3.13
- IMAB $0.60
- 52 Week High
- FPH $6.71
- IMAB $5.90
- Technical
- Relative Strength Index (RSI)
- FPH 59.40
- IMAB 49.40
- Support Level
- FPH $5.85
- IMAB $3.20
- Resistance Level
- FPH $6.11
- IMAB $4.64
- Average True Range (ATR)
- FPH 0.16
- IMAB 0.44
- MACD
- FPH 0.04
- IMAB -0.15
- Stochastic Oscillator
- FPH 66.67
- IMAB 38.01
About FPH Five Point Holdings LLC
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).